Lannett Company
LCI
$0.69
Share price
0.00%
Change (1 day)
-69.93%
Change (1 year)
Categories
P/S ratio for Lannett Company (LCI)
P/S ratio as of May 2024 (TTM): 0.0238
According to Lannett Company's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.0237568. At the end of 2023 the company had a P/S ratio of 0.0603.
P/S ratio history for Lannett Company from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.0603 | -14.85% |
| 2022 | 0.0708 | -58.97% |
| 2021 | 0.1726 | -65.55% |
| 2020 | 0.5010 | -16.32% |
| 2019 | 0.5987 | 121.51% |
| 2018 | 0.2703 | -80.09% |
| 2017 | 1.36 | 10.22% |
| 2016 | 1.23 | -63.6% |
| 2015 | 3.38 | -18.45% |
| 2014 | 4.15 | -30.81% |
| 2013 | 6.00 | 489% |
| 2012 | 1.02 | -12.19% |
| 2011 | 1.16 | -11.77% |
| 2010 | 1.31 | 11.55% |
| 2009 | 1.18 | -11.32% |
| 2008 | 1.33 | 29.69% |
| 2007 | 1.02 | -45.53% |
| 2006 | 1.88 | -51.33% |
| 2005 | 3.87 | 0.82% |
| 2004 | 3.83 | -39.74% |
| 2003 | 6.36 | 2.14% |
| 2002 | 6.23 | 135.86% |
| 2001 | 2.64 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.86 | 16,156.15% | 🇺🇸 USA |
 Novartis NVS | 3.98 | 16,633.99% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.69 | 11,231.58% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.59 | 19,234.04% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2.34 | 9,764.29% | 🇬🇧 UK |